In its first edition, Therapeutic Area Partnerships: Women’s Health, is positioned to help industry leaders develop meaningful partnerships and explore bold new ideas to overcome healthcare’s biggest challenges.

Eurocine Vaccines will participate virtually to build its network in the area and to share progress in the Chlamydia vaccine development – our contribution to improve women´s health by preventing chlamydia infection and its complications, e.g. infertility and ectopic pregnancy.

“A cultural shift is taking place in openly expressing and understanding women’s suffering, allowing the market to evolve significantly. Combined with advancements in technologies and diagnostics, there is an opportunity for even more growth in this space.”